Literature DB >> 2374912

Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study.

C Isles1, J Main, J O'Connell, I Brown, J Findlay, R Stewart, R Wilkinson.   

Abstract

Data from 121 consecutive patients with hypertension and renovascular disease, first diagnosed between 1975 and 1982 in Glasgow and Newcastle, were analysed retrospectively to determine the factors which influenced their outcome. Thirty-six patients died between the data of arteriography and 1st January 1987, giving five and ten year survival rates of 83% and 67%. Survival was greatly reduced in comparison with that of age-sex-matched controls in the general population of the West of Scotland, and was also less than that of essential hypertensives matched for age, sex, initial diastolic blood pressure and smoking habit who had attended the Glasgow Blood Pressure Clinic during the same period. Multivariate analysis showed that age, cigarette smoking and presence of atheromatous disease were significantly and independently related to outcome among the patients with renovascular disease, whereas male sex, centre of origin, severity of hypertension when first seen, initial renal function and presence of bilateral disease were not. Despite a trend towards benefit from surgical intervention (ten year survival in medical group 62%, in surgical group 71%; p = 0.19) our data do not prove that intervention is better than medical treatment, largely because the decision on intervention was not randomised. A prospective trial would be required to answer this important question.

Entities:  

Mesh:

Year:  1990        PMID: 2374912     DOI: 10.1177/003693309003500303

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  8 in total

Review 1.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

2.  Long-Term Outcomes and Causes of Death in Patients With Renovascular Disease Undergoing Renal Artery Stenting.

Authors:  Eric L Wallace; Ediz Tasan; Bryon S Cook; Richard Charnigo; Ahmed K Abdel-Latif; Khaled M Ziada
Journal:  Angiology       Date:  2015-09-30       Impact factor: 3.619

Review 3.  Atherosclerotic renal artery stenosis--diagnosis and treatment.

Authors:  David Lao; Punit S Parasher; Kerry C Cho; Yerem Yeghiazarians
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

4.  Renal ischemia regulates marinobufagenin release in humans.

Authors:  Jiang Tian; Steven Haller; Sankaridrug Periyasamy; Pamela Brewster; Haifeng Zhang; Satjit Adlakha; Olga V Fedorova; Zi-Jian Xie; Alexei Y Bagrov; Joseph I Shapiro; Christopher J Cooper
Journal:  Hypertension       Date:  2010-09-07       Impact factor: 10.190

Review 5.  Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.

Authors:  Faical Jarraya; Menno Pruijm; Gregoire Wuerzner; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 6.  Atherosclerotic renovascular disease and renal impairment: can we predict the effect of intervention?

Authors:  Kwok-Wai Mui; Arend-Jan Woittiez; Gerjan Navis
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 5.369

Review 7.  Cardiovascular morbidity and mortality and renal artery stenosis.

Authors:  William R Colyer; Christopher J Cooper
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

8.  OSTIAL VERSUS TRUNCAL RENAL ARTERY STENOSIS: PREDICTOR OF LARGE ARTERY ATHEROSCLEROSIS SEVERITY AND HIGHER MORTALITY.

Authors:  Dražen Perkov; Vedran Premužić; Ranko Smiljanić; Ljiljana Fodor; Savko Dobrota; Bojan Jelaković
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.